FDA declines approval bid for Neffy, a needle-free EpiPen alternative
ASR Pharma said it was surprised and "deeply disappointed" by the FDA request for more trial data on its Neffy nasal spray for severe allergic reactions.
Watch CBS News
ASR Pharma said it was surprised and "deeply disappointed" by the FDA request for more trial data on its Neffy nasal spray for severe allergic reactions.
Two young men were on a fish trip when suddenly life and death were in the balance.
The Food and Drug Administration has issued a warning about a problem that with some EpiPens.
An EpiPen shortage has people with severe allergies worried, especially as school returns.
The U.S. Food and Drug Administration on Thursday announced the approval of the first generic version of EpiPen.
Mylan Labs is about to launch a new drug that could revolutionize the way cancer is treated, and it could make it cheaper.
Sharon police officers saved the life of a woman who was going into anaphylactic shock Friday morning.
Some big pension funds are attempting to block the re-election of a number of Mylan board members
A recall of the emergency anti-allergy medicine EpiPen is expanding to the U.S. and other markets in North America, Europe, Asia and South America because the allergy shots may not work.
Four batches of EpiPens are being recalled because they may fail to activate or require increased force.
Pharmaceutical giant Mylan, which is based in Canonsburg, was at the center of criticism last year over rising drug prices.
Drug store chain CVS is now offering a competitor to EpiPen, a device for self-administering injectable medicine to stop a severe allergic reaction.
Mylan revealed it's the target of two price-related probes by federal agencies and has had its premises searched.
Leaders of the House Oversight Committee want EpiPen maker Mylan to explain why the company's CEO apparently misled Congress about profits the company claimed for the life-saving EpiPen injection device.
The Mylan CEO faced tough words from members of a congressional investigations committee Wednesday.
Much has been made recently about the astronomical price-hike on EpiPens, but that's not the only prescription that's gone up in price recently. The price on hundreds of drugs has skyrocketed without much notice.
West Virginia Attorney General Patrick Morrisey has subpoenaed drug company Mylan N.V. in an investigation over drastic price hikes for its EpiPen.
The head of Mylan will face lawmakers' questions at a hearing next week on steep price hikes for the company's life-saving EpiPen injector device.
Mylan Pharmaceuticals has been in the spotlight lately for hiking the price of a life-saving allergy medicine, but even with a reduced price, EpiPens still cost hundreds of dollars.
In a sign of growing concern in Congress, 20 Democratic senators are demanding answers about steep price hikes for the life-saving EpiPen injector device.
Mylan says it will make available a generic version of its EpiPen, as criticism continued to mount over the price of its injectable medicine.
Local and national health care advocates are demanding change.
The price of a lifesaving EpiPen has skyrocketed, and that's putting people with severe allergic reactions at risk.
Mylan, in the face of heated criticism over price hikes for its EpiPen emergency allergy treatment, is bulking up programs that help patients pay for the drug.
The price of the lifesaving drug, the EpiPen, has jumped from $100 for a two-pack seven years ago to over $600 today.
